Alphamol Science Ltd. (shanghai)

This early-stage study is testing a new drug, Alpha-0261, for the first time in people. The goal is to see if it is safe and how the body processes it. About 60 healthy adults will receive a single dose of the drug or a placebo. No treatment benefit is expected; the study is pure…